The Development of a Multitarget, Multicolor Fluorescence in Situ Hybridization Assay for the Detection of Urothelial Carcinoma in Urine

Campbell's Urology, 7th ed.WalshP.C.: Philadelphia: Lippincott Williams & Wilkins. Philadelphia: W. B. Saunders Co.1998. 210 pages.RetikA.B.: Philadelphia: Lippincott Williams & Wilkins. Philadelphia: W. B. Saunders Co.1998. 210 pages.VaughanE.D.: Philadelphia: Lippincott Williams & Wilkins. Philadelphia: W. B. Saunders Co.1998. 3,426 pages.WeinA.J.: Philadelphia: Lippincott Williams & Wilkins. Philadelphia: Isis Medical Media Ltd.1998. 3,426 pages.

1998 • 429 citations

Urothelial Tumors of the Urinary Tract

1992 • 388 citations

A COMPARISON OF CYTOLOGY AND FLUORESCENCE IN SITU HYBRIDIZATION FOR THE DETECTION OF UROTHELIAL CARCINOMA

2000 • 387 citations

COMPARISON OF SCREENING METHODS IN THE DETECTION OF BLADDER CANCER

1999 • 329 citations

Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization.

1997 • 250 citations

Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer

1998 • 238 citations

Numerical chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybridization.

1991 • 233 citations

Improved detection of recurrent bladder cancer using the bard bta stat test

1997 • 195 citations

Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9.

1993 • 187 citations

Deletion of the p16 and p15 Genes in Human Bladder Tumors

1995 • 185 citations

Review of Chromosome Studies in Urological Tumors. II. Cytogenetics and Molecular Genetics of Bladder Cancer

1994 • 171 citations

Evidence for two bladder cancer suppressor loci on human chromosome 9.

1993 • 143 citations

Clinical evaluation of the BTA trak assay and comparison to voided urine cytology and the bard BTA test in patients with recurrent bladder tumors

1997 • 139 citations

A Multicenter Trial Evaluation of the Fibrin/Fibrinogen Degradation Products Test for Detection and Monitoring of Bladder Cancer

1997 • 122 citations

Partial allelotype of carcinoma in situ of the human bladder.

1995 • 116 citations

Multicenter trial of the quantitative BTA TRAK assay in the detection of bladder cancer.

1999 • 110 citations

Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa).

1999 • 110 citations

Cytology, flow cytometry, image analysis, and interphase cytogenetics by fluorescence in situ hybridization in the diagnosis of transitional cell carcinoma in bladder washes: A comparative study

1995 • 96 citations

Identification of H-ras Mutations in Urine Sediments Complements Cytology in the Detection of Bladder Tumors

1995 • 93 citations

Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer.

1994 • 87 citations

Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens.

1996 • 77 citations

A new approach in the diagnosis and follow-up of bladder cancer

1993 • 76 citations

The clinical value of urinary cytology: 12 years of experience with 615 patients.

1995 • 74 citations

Molecular genetics and biochemical mechanisms in bladder cancer. Oncogenes, tumor suppressor genes, and growth factors.

1992 • 64 citations

Bladder irrigation specimens assayed by fluorescence in situ hybridization to interphase nuclei

1994 • 62 citations

Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization

1997 • 58 citations

Origins and clinical implications of aneuploidy in early bladder cancer

1995 • 57 citations

Fluorescence in situ hybridization identifies more aggressive types of primarily noninvasive (stage pTa) bladder cancer.

1997 • 53 citations

DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH

1997 • 49 citations

MOLECULAR GENETICS AND BIOCHEMICAL MECHANISMS IN BLADDER CANCER

1992 • 47 citations

Fluorescence in Situ Hybridization Identifies More Aggressive Types of Primarily Noninvasive (Stage pTa) Bladder Cancer

1997 • 46 citations

Bard® BTA® Test Compared with Diagnosis of Recurrent Bladder Cancer

1997 • 45 citations

The Bard<sup>&reg;</sup> BTA Test: Its Mode of Action, Sensitivity and Specificity, Compared to Cytology of Voided Urine, in the Diagnosis of Superficial Bladder Cancer

1998 • 43 citations

Clinical Evaluation of Cell Deoxyribonucleic Acid Content Measured by Flow Cytometry in Bladder Cancer

1996 • 42 citations

Molecular genetics of bladder cancer.

1995 • 41 citations

Toward the validation of aneusomy detection by fluorescence in situ hybridization in bladder cancer: comparative analysis with cytology, cytogenetics, and clinical features predicts recurrence and defines clinical testing limitations.

1997 • 37 citations

Interphase cytogenetics as an adjunct in the cytodiagnosis of urinary bladder carcinoma. A comparative study of cytology, flow cytometry and interphase cytogenetics in bladder washes.

1994 • 33 citations

Flow cytometry versus urinary cytology in the diagnosis and follow-up of bladder tumors: critical review of a 5-year experience

1993 • 21 citations

Detection of Genetic Aberrations in Bladder Cancer Using in Situ Hybridizationa

1993 • 14 citations

Intratumoral Heterogeneity in DNA Ploidy of Bladder Carcinomas

1992 • 14 citations

Cited By (0)

Loading...